FDA GAO Report on Access to REMS Drugs Shows Mixed Views on Path Forward Thomas Sullivan Jan 3, 2020 0 The GAO recently published a report, entitled Generic Drug Development – Stakeholders’ Views of Risk Evaluation and Mitigation…
